Yanzhu Lin

GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice

Ricardo J. Samms, Michael E. Christe, Kyla Collins et al. · Journal of Clinical Investigation · 2021 · 227 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Comparison of normalization and differential expression analyses using RNA-Seq data from 726 individual Drosophila melanogaster

Yanzhu Lin, Kseniya Golovnina, Zhen‐Xia Chen et al. · BMC Genomics · 2016 · 189 citations · Full text

Life Sciences, Biology, Genetics +16

The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A p <scp>ost hoc</scp> analysis

Jonathan M. Wilson, Yanzhu Lin, Mengdie Luo et al. · Diabetes Obesity and Metabolism · 2021 · 128 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes

Valentina Pirro, Kenneth D. Roth, Yanzhu Lin et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 113 citations

Medicine, Endocrinology, Pharmacology +17

Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor

Ajit Regmi, Eitaro Aihara, Michael E. Christe et al. · Cell Metabolism · 2024 · 101 citations · Full text

Medicine, Endocrinology, Pharmacology +17